Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign†
Article first published online: 1 DEC 2011
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 124, Issue 7, pages 1595–1599, February 13, 2012
How to Cite
Bhattacharyya, S., Singh, R. D., Pagano, R., Robertson, J. D., Bhattacharya, R. and Mukherjee, P. (2012), Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign. Angew. Chem., 124: 1595–1599. doi: 10.1002/ange.201105432
This work was supported by the National Institutes of Health (NIH) grants CA135011, and CA136494 to P.M. We are thankful to John Charlesworth and Cindy B. Uhl for helping with TEM image analysis. We gratefully acknowledge James E. Tarara for helping with confocal image analysis. We also acknowledge Prof. Cord Brakebusch and Mark McNiven for providing the Cdc42-null cells and the EGFR-GFP construct, respectively.
- Issue published online: 7 FEB 2012
- Article first published online: 1 DEC 2011
- Manuscript Revised: 9 NOV 2011
- Manuscript Received: 1 AUG 2011
- National Institutes of Health
- NIH. Grant Numbers: CA135011, CA136494
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.